Danaher | DHR - Assets

Stock Price
177.25
Daily Change
-1.32 -0.74%
Monthly
-5.29%
Yearly
-10.09%
Q2 Forecast
173.46

Danaher reported $83.54B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Agilent USD 12.81B 86M Dec/2025
Align Technology USD 6.23B 141K Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio Techne USD 2.52B 3.45M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.43B 224M Dec/2025
Edwards Lifesciences USD 13.7B 425M Dec/2025
ESCO Technologies USD 2.4B 11.39M Dec/2025
Fortive USD 11.74B 149M Dec/2025
Henry Schein USD 11.22B 118M Dec/2025
Illumina USD 6.64B 467M Dec/2025
Intuitive Surgical USD 20.11B 347.7M Mar/2026
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Keysight Technologies USD 11.48B 188M Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Myriad Genetics USD 706.6M 21.5M Dec/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Quest Diagnostics USD 16.67B 448M Mar/2026
Quidel USD 5.77B 94.2M Dec/2025
Repligen USD 2.95B 25.99M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Roper Industries USD 34.55B 26.2M Mar/2026
Stryker USD 47.84B 787M Dec/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Waters USD 5.08B 221.41M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025